AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 9177418 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbimazole plus high dose CT (Calsynar; 100 IU/day, 14 days/month)
Number of subjects: 45
Study 9177418 — intervention group
Group type: COMPARATOR
Intervention: Carbimazole (Neotomizol)
Number of subjects: 45
Study 9177418 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasal calcitonin (CT)
Number of subjects: 45
Study 9177418 — intervention group
Group type: EXPERIMENTAL
Intervention: All treatments
Number of subjects: 45
Study 8426767 — intervention group
Group type: EXPERIMENTAL
Intervention: Antibiotic treatment for upper respiratory infections
Number of subjects: 0
Study 8426767 — intervention group
Group type: COMPARATOR
Intervention: Control (no antibiotic treatment)
Number of subjects: 0
Study 3429867 — intervention group
Group type: EXPERIMENTAL
Intervention: AII/NA infusion
Number of subjects: 10
Study 3429867 — intervention group
Group type: EXPERIMENTAL
Intervention: Dextrose/NA infusion
Number of subjects: 10
Study 3429867 — intervention group
Group type: EXPERIMENTAL
Intervention: All/saline infusion
Number of subjects: 10
Study 3429867 — intervention group
Group type: COMPARATOR
Intervention: Dextrose/saline infusion
Number of subjects: 10
Study 30243962 — intervention group
Group type: EXPERIMENTAL
Intervention: TR band (TRG)
Number of subjects: 320
Study 30243962 — intervention group
Group type: COMPARATOR
Intervention: Safeguard Radial (SGG)
Number of subjects: 320
Study 25989426 — intervention group
Group type: EXPERIMENTAL
Intervention: Mediterranean diet (MD) combined with physical activity
Number of subjects: 124
Study 25989426 — intervention group
Group type: COMPARATOR
Intervention: Standard hypolypemic diet (SHD) with physical activity
Number of subjects: 124
Study 25552280 — intervention group
Group type: EXPERIMENTAL
Intervention: Re‐feeding group
Number of subjects: 72
Study 25552280 — intervention group
Group type: COMPARATOR
Intervention: Fresh‐feeding group
Number of subjects: 72
Study 23961701 — intervention group
Group type: COMPARATOR
Intervention: Implementation strategies used in children's social service organizations
Number of subjects: 7
Study 23961701 — intervention group
Group type: COMPARATOR
Intervention: Web-based survey assessing perceived effectiveness, relative importance, acceptability, feasibility, and appropriateness of implementation strategies
Number of subjects: 7
Study 23961701 — intervention group
Group type: COMPARATOR
Intervention: Organizational Social Context measure
Number of subjects: 7
Study 21867385 — intervention group
Group type: EXPERIMENTAL
Intervention: Beliefs that Alzheimer's disease can be prevented
Number of subjects: 139
Study 21867385 — intervention group
Group type: EXPERIMENTAL
Intervention: Beliefs that Alzheimer's disease is preventable
Number of subjects: 139
Study 21867385 — intervention group
Group type: EXPERIMENTAL
Intervention: Engagement in behaviors to prevent Alzheimer's disease
Number of subjects: 139
Study 21867385 — intervention group
Group type: COMPARATOR
Intervention: Manipulation of beliefs about AD preventability
Number of subjects: 139
Study 19325202 — intervention group
Group type: EXPERIMENTAL
Intervention: Test dentifrice containing nano-sized calcium carbonate (NC)
Number of subjects: 0
Study 19325202 — intervention group
Group type: COMPARATOR
Intervention: Placebo dentifrice without NC
Number of subjects: 0
Study 17003850 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 mg exogenous melatonin orally
Number of subjects: 15
Study 17003850 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 mg exogenous melatonin orally + CYP2C19 substrate
Number of subjects: 15
Study 17003850 — intervention group
Group type: COMPARATOR
Intervention: placebo + CYP2C19 substrate
Number of subjects: 15
Study 17003850 — intervention group
Group type: EXPERIMENTAL
Intervention: melatonin treatment
Number of subjects: 15
Study 15486168 — intervention group
Group type: EXPERIMENTAL
Intervention: Authentic CBTI reports
Number of subjects: 41
Study 15486168 — intervention group
Group type: COMPARATOR
Intervention: Modal CBTI reports
Number of subjects: 41
Study 15486168 — intervention group
Group type: EXPERIMENTAL
Intervention: Automated Assessment Associates' report
Number of subjects: 41
Study 15486168 — intervention group
Group type: EXPERIMENTAL
Intervention: Western Psychological Services, Pearson Assessments, Caldwell Report
Number of subjects: 41
Study 11277319 — intervention group
Group type: EXPERIMENTAL
Intervention: Megestrol acetate (MA) 480 mg/day during RT
Number of subjects: 100
Study 11277319 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 9079231 — intervention group
Group type: EXPERIMENTAL
Intervention: NTG oral spray (Myocor Spray)
Number of subjects: 17
Study 9079231 — intervention group
Group type: COMPARATOR
Intervention: Sublingual tablet
Number of subjects: 17
Study 8421422 — intervention group
Group type: EXPERIMENTAL
Intervention: Three courses of cis-platinum containing chemotherapy
Number of subjects: 112
Study 8421422 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment of surgery and postoperative radiotherapy
Number of subjects: 112
Study 3784136 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical forskolin (50 microliter of 1% forskolin)
Number of subjects: 20
Study 3784136 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical forskolin (two instillations)
Number of subjects: 20
Study 3784136 — intervention group
Group type: COMPARATOR
Intervention: Topical 0.25% 1-timolol (pretreatment)
Number of subjects: 20
Study 30112725 — intervention group
Group type: EXPERIMENTAL
Intervention: DFN-11 (3 mg sumatriptan injection)
Number of subjects: 234
Study 27502706 — intervention group
Group type: EXPERIMENTAL
Intervention: RCHOP (Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, Prednisone)
Number of subjects: 0
Study 27502706 — intervention group
Group type: EXPERIMENTAL
Intervention: Targeted therapies
Number of subjects: 0
Study 27502706 — intervention group
Group type: COMPARATOR
Intervention: Consensus-based treatment
Number of subjects: 0
Study 24819570 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-literacy, primary-care intervention using an interactive educational toolkit and clinician-centered curriculum for obesity prevention.
Number of subjects: 865
Study 24819570 — intervention group
Group type: COMPARATOR
Intervention: Attention-control arm implementing the American Academy of Pediatrics' The Injury Prevention Program.
Number of subjects: 865
Study 23045660 — intervention group
Group type: EXPERIMENTAL
Intervention: Foster Care Group (FCG)
Number of subjects: 3
Study 23045660 — intervention group
Group type: EXPERIMENTAL
Intervention: Never-Institutionalized Group (NIG)
Number of subjects: 3
Study 23045660 — intervention group
Group type: COMPARATOR
Intervention: Care As Usual Group (CAUG)
Number of subjects: 3
Study 23045660 — intervention group
Group type: EXPERIMENTAL
Intervention: Foster Care Group (FCG) placed after 20 months
Number of subjects: 3
Study 23045660 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroencephalogram alpha power
Number of subjects: 3
Study 20156980 — intervention group
Group type: EXPERIMENTAL
Intervention: Errorless learning intervention (n = 15)
Number of subjects: 30
Study 20156980 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual control (n = 15)
Number of subjects: 30
Study 18551027 — intervention group
Group type: EXPERIMENTAL
Intervention: Ramipril treatment group
Number of subjects: 1008
Study 18551027 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 1008
Study 16334717 — intervention group
Group type: EXPERIMENTAL
Intervention: External application of Chinese drugs on acupoint Shenque (CV 8) combined with salpingostomy
Number of subjects: 75
Study 16334717 — intervention group
Group type: COMPARATOR
Intervention: Salpingostomy only
Number of subjects: 75
Study 12888366 — intervention group
Group type: EXPERIMENTAL
Intervention: Goserelin (Zoladex)
Number of subjects: 0
Study 12888366 — intervention group
Group type: COMPARATOR
Intervention: CMF chemotherapy
Number of subjects: 0
Study 10389801 — intervention group
Group type: EXPERIMENTAL
Intervention: Air-filled endotracheal cuff inflated to 30-40 cm H2O
Number of subjects: 65
Study 10389801 — intervention group
Group type: COMPARATOR
Intervention: Gas mixture (N2O 50% in oxygen)
Number of subjects: 65
Study 8545199 — intervention group
Group type: EXPERIMENTAL
Intervention: Synthetic surfactant (Exosurf Neonatal, n = 644)
Number of subjects: 1296
Study 8545199 — intervention group
Group type: COMPARATOR
Intervention: Modified bovine surfactant extract (Survanta, n = 652)
Number of subjects: 1296
Study 8545199 — intervention group
Group type: COMPARATOR
Intervention: Modified bovine surfactant extract (Survanta)
Number of subjects: 1296
Study 8469318 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.6 million international units (MIU) of IFNB
Number of subjects: 372
Study 8469318 — intervention group
Group type: EXPERIMENTAL
Intervention: 8 MIU of IFNB
Number of subjects: 372
Study 8469318 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 372
Study 3885963 — intervention group
Group type: EXPERIMENTAL
Intervention: Flupirtine 100 mg capsules
Number of subjects: 52
Study 3885963 — intervention group
Group type: COMPARATOR
Intervention: Pentazocine 50 mg capsules
Number of subjects: 52
Study 29550015 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiac Magnetic Resonance (CMR) evaluation
Number of subjects: 0
Study 27780772 — intervention group
Group type: EXPERIMENTAL
Intervention: ERAS program with extended stoma education (n=61)
Number of subjects: 122
Study 27780772 — intervention group
Group type: COMPARATOR
Intervention: Standard care with current stoma education (n=61)
Number of subjects: 122
Study 25543606 — intervention group
Group type: EXPERIMENTAL
Intervention: Fixed Twin-block combined with fixed appliance
Number of subjects: 31
Study 25543606 — intervention group
Group type: COMPARATOR
Intervention: Fixed appliance after tooth extraction
Number of subjects: 31
Study 22424890 — intervention group
Group type: EXPERIMENTAL
Intervention: Bright light therapy
Number of subjects: 44
Study 22424890 — intervention group
Group type: COMPARATOR
Intervention: Low-density negative ion generator
Number of subjects: 44
Study 22424890 — intervention group
Group type: COMPARATOR
Intervention: High-density negative ion generator
Number of subjects: 44
Study 22424890 — intervention group
Group type: EXPERIMENTAL
Intervention: Adverse events assessed using Young Mania Rating Scale (YMRS) and Systematic Assessment for Treatment Emergent effects (SAFTEE)
Number of subjects: 44
Study 20439846 — intervention group
Group type: EXPERIMENTAL
Intervention: 150 mg of mexiletine 3 times daily
Number of subjects: 20
Study 20439846 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg of mexiletine 3 times daily
Number of subjects: 20
Study 20439846 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 17869557 — intervention group
Group type: EXPERIMENTAL
Intervention: Skin-to-skin contact for 15 min before, during and following heel prick (n=31)
Number of subjects: 59
Study 17869557 — intervention group
Group type: COMPARATOR
Intervention: Regular care (n=28)
Number of subjects: 59
Study 16012932 — intervention group
Group type: EXPERIMENTAL
Intervention: Colonoscopic surveillance
Number of subjects: 2915
Study 12424317 — intervention group
Group type: EXPERIMENTAL
Intervention: Training to improve contour detection
Number of subjects: 0
Study 12424317 — intervention group
Group type: EXPERIMENTAL
Intervention: Colinear alignment of nearby segments
Number of subjects: 0
Study 12424317 — intervention group
Group type: EXPERIMENTAL
Intervention: Short contour spacing
Number of subjects: 0
Study 12424317 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermediate spacing with colinear lines
Number of subjects: 0
Study 12424317 — intervention group
Group type: EXPERIMENTAL
Intervention: Spacing beyond critical range (about 2 degrees)
Number of subjects: 0
Study 10491235 — intervention group
Group type: EXPERIMENTAL
Intervention: Return visits
Number of subjects: 212
Study 10491235 — intervention group
Group type: COMPARATOR
Intervention: Initial visits
Number of subjects: 212
Study 8735678 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluvastatin (40 mg)
Number of subjects: 16
Study 8735678 — intervention group
Group type: EXPERIMENTAL
Intervention: Bezafibrate (400 mg)
Number of subjects: 16
Study 1913227 — intervention group
Group type: EXPERIMENTAL
Intervention: FEC (fluorouracil, epirubicin, and cyclophosphamide)
Number of subjects: 60
Study 1913227 — intervention group
Group type: COMPARATOR
Intervention: FNC (fluorouracil, mitoxantrone, and cyclophosphamide)
Number of subjects: 60
Study 6092982 — intervention group
Group type: EXPERIMENTAL
Intervention: LoNaHCO3 dialysis (sodium bicarbonate, Na = 134, HCO3 = 33 mEq/l)
Number of subjects: 6
Study 6092982 — intervention group
Group type: EXPERIMENTAL
Intervention: HiNaAc dialysis (high sodium acetate, Na = 144, acetate = 33 mEq/l)
Number of subjects: 6
Study 6092982 — intervention group
Group type: COMPARATOR
Intervention: LoNaAc dialysis (sodium acetate, Na = 134, acetate = 33 mEq/l)
Number of subjects: 6
Study 6092982 — intervention group
Group type: EXPERIMENTAL
Intervention: LoNaHCO3 dialysis
Number of subjects: 6
Study 6092982 — intervention group
Group type: EXPERIMENTAL
Intervention: HiNaAc dialysis
Number of subjects: 6
Study 29664328 — intervention group
Group type: EXPERIMENTAL
Intervention: Social reference
Number of subjects: 292
Study 29664328 — intervention group
Group type: EXPERIMENTAL
Intervention: Advertisement
Number of subjects: 292
Study 29664328 — intervention group
Group type: EXPERIMENTAL
Intervention: Attitude toward the system
Number of subjects: 292
Study 29664328 — intervention group
Group type: EXPERIMENTAL
Intervention: Access to cellphone
Number of subjects: 292
Study 29664328 — intervention group
Group type: EXPERIMENTAL
Intervention: Perceived system effectiveness
Number of subjects: 292
Study 29664328 — intervention group
Group type: EXPERIMENTAL
Intervention: Demographic variables (age, gender, education)
Number of subjects: 292
Study 29664328 — intervention group
Group type: COMPARATOR
Intervention: Monthly family expenditure
Number of subjects: 292
Study 30286130 — intervention group
Group type: EXPERIMENTAL
Intervention: SST training plus standard rehabilitation program
Number of subjects: 75
Study 30286130 — intervention group
Group type: COMPARATOR
Intervention: Standard rehabilitation program (Control)
Number of subjects: 75
Study 27814860 — intervention group
Group type: EXPERIMENTAL
Intervention: Static stretching
Number of subjects: 32
Study 27814860 — intervention group
Group type: EXPERIMENTAL
Intervention: Pilates
Number of subjects: 32
Study 24725198 — intervention group
Group type: EXPERIMENTAL
Intervention: SGA Disc Group (discontinued risperidone)
Number of subjects: 101
Study 24725198 — intervention group
Group type: COMPARATOR
Intervention: Risp Cont Group (continued risperidone)
Number of subjects: 101
Study 24725198 — intervention group
Group type: COMPARATOR
Intervention: SGA Cont Group (switched to another SGA)
Number of subjects: 101
Study 24725198 — intervention group
Group type: EXPERIMENTAL
Intervention: Change in BMI z score
Number of subjects: 101
Study 22345126 — intervention group
Group type: EXPERIMENTAL
Intervention: Dalcetrapib 600 mg/day
Number of subjects: 476
Study 22345126 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 476
Study 20149752 — intervention group
Group type: EXPERIMENTAL
Intervention: Interactive multimedia (IMM) food safety education program on a computer kiosk
Number of subjects: 176
Study 17365885 — intervention group
Group type: EXPERIMENTAL
Intervention: C-leg microprocessor-controlled prosthetic knee
Number of subjects: 13
Study 17365885 — intervention group
Group type: COMPARATOR
Intervention: Non-microprocessor control (NMC) prosthetic knees
Number of subjects: 13
Study 15625424 — intervention group
Group type: EXPERIMENTAL
Intervention: Infant formula with 0.8 g/100 ml GOS/FOS (OSF group)
Number of subjects: 2
Study 15625424 — intervention group
Group type: COMPARATOR
Intervention: Control formula (SF group)
Number of subjects: 2
Study 12045365 — intervention group
Group type: EXPERIMENTAL
Intervention: Omapatrilat
Number of subjects: 83
Study 12045365 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 83
Study 9656585 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 ml of iodised oil (Lipiodol®) administered orally in Namentenga
Number of subjects: 423
Study 9656585 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 ml of iodised oil (Lipiodol®) administered IM in Passore
Number of subjects: 423
Study 7893024 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupivacaine (1 mg/kg of 0.5% bupivacaine with epinephrine 1:200000 in 20 mL of saline 0.9%)
Number of subjects: 0
Study 7893024 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine (3 mg/kg of 2% lidocaine with epinephrine in 20 mL of saline 0.9%)
Number of subjects: 0
Study 7893024 — intervention group
Group type: COMPARATOR
Intervention: Placebo (20 mL of saline 0.9%)
Number of subjects: 0
Study 2505216 — intervention group
Group type: EXPERIMENTAL
Intervention: 80 mg tobramycin solution, inhaled 3 times daily (15 patients)
Number of subjects: 27
Study 2505216 — intervention group
Group type: COMPARATOR
Intervention: 2 mL saline, inhaled 3 times daily (12 patients)
Number of subjects: 27
Study 11284 — intervention group
Group type: EXPERIMENTAL
Intervention: Group I (normal labor with spontaneous rupture of membranes)
Number of subjects: 38
Study 11284 — intervention group
Group type: COMPARATOR
Intervention: Group II (labor with artificial rupture of membranes)
Number of subjects: 38
Study 31056373 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemical foot warmers applied to handheld ultrasound machines
Number of subjects: 0
Study 31056373 — intervention group
Group type: COMPARATOR
Intervention: Control group (no chemical foot warmers)
Number of subjects: 0
Study 28281433 — intervention group
Group type: EXPERIMENTAL
Intervention: Operative laparoscopy
Number of subjects: 140
Study 28281433 — intervention group
Group type: COMPARATOR
Intervention: Laparotomy
Number of subjects: 140
Study 25153922 — intervention group
Group type: EXPERIMENTAL
Intervention: Cane fitted to the greater trochanter (GT)
Number of subjects: 16
Study 25153922 — intervention group
Group type: COMPARATOR
Intervention: Cane fitted to the wrist crease (WC)
Number of subjects: 16
Study 23859894 — intervention group
Group type: EXPERIMENTAL
Intervention: Gradual Decompression (GD)
Number of subjects: 294
Study 23859894 — intervention group
Group type: COMPARATOR
Intervention: Rapid Decompression (RD)
Number of subjects: 294
Study 23859894 — intervention group
Group type: EXPERIMENTAL
Intervention: Both GD and RD
Number of subjects: 294
Study 21810191 — intervention group
Group type: EXPERIMENTAL
Intervention: Niacin (up to 1,500 mg daily for 12 weeks)
Number of subjects: 160
Study 21810191 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 160
Study 21810191 — intervention group
Group type: EXPERIMENTAL
Intervention: Niacin (for moderate ED)
Number of subjects: 160
Study 21810191 — intervention group
Group type: EXPERIMENTAL
Intervention: Niacin (for severe ED)
Number of subjects: 160
Study 21810191 — intervention group
Group type: COMPARATOR
Intervention: Placebo (for severe ED)
Number of subjects: 160
Study 21810191 — intervention group
Group type: COMPARATOR
Intervention: Placebo (for moderate ED)
Number of subjects: 160
Study 21810191 — intervention group
Group type: EXPERIMENTAL
Intervention: Niacin (for patients not receiving statins)
Number of subjects: 160
Study 19472972 — intervention group
Group type: EXPERIMENTAL
Intervention: Sequential bilateral TKA under 1 anesthetic
Number of subjects: 70
Study 19472972 — intervention group
Group type: COMPARATOR
Intervention: Unilateral TKA
Number of subjects: 70
Study 17491170 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet smoking cessation service (www.QuitNet.com)
Number of subjects: 764
Study 17491170 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet smoking cessation service (www.QuitNet.com) with telephone counseling
Number of subjects: 764
Study 17491170 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 764
Study 15028366 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiac rehabilitation and exercise training for three months
Number of subjects: 277
Study 15028366 — intervention group
Group type: COMPARATOR
Intervention: Control group (did not attend cardiac rehabilitation)
Number of subjects: 277
Study 11354235 — intervention group
Group type: COMPARATOR
Intervention: 50 mg of sertraline
Number of subjects: 91
Study 11354235 — intervention group
Group type: EXPERIMENTAL
Intervention: 150 mg of sertraline
Number of subjects: 91
Study 9442548 — intervention group
Group type: EXPERIMENTAL
Intervention: Sulpiride (200 mg/day)
Number of subjects: 0
Study 9442548 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 7970587 — intervention group
Group type: EXPERIMENTAL
Intervention: Anterior lateral surgical approach
Number of subjects: 40
Study 7970587 — intervention group
Group type: COMPARATOR
Intervention: Medial surgical approach
Number of subjects: 40
Study 3107808 — intervention group
Group type: EXPERIMENTAL
Intervention: Total Parenteral Nutrition (TPN)
Number of subjects: 57
Study 3107808 — intervention group
Group type: COMPARATOR
Intervention: Enteral Feeding Program
Number of subjects: 57
Study 3107808 — intervention group
Group type: EXPERIMENTAL
Intervention: Total Parenteral Nutrition (TPN) and Enteral Feeding Program
Number of subjects: 57
Study 31918704 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile health intervention (interactive voice call and call center)
Number of subjects: 18
Study 31918704 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 18
Study 29609566 — intervention group
Group type: EXPERIMENTAL
Intervention: Regular pulsatile cupping with 8 treatments plus paracetamol on demand (n=37)
Number of subjects: 110
Study 29609566 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimal cupping with 8 treatments plus paracetamol on demand (n=36)
Number of subjects: 110
Study 29609566 — intervention group
Group type: COMPARATOR
Intervention: Control group with paracetamol on demand only (n=37)
Number of subjects: 110
Study 29609566 — intervention group
Group type: EXPERIMENTAL
Intervention: Regular pulsatile cupping
Number of subjects: 110
Study 29609566 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimal cupping
Number of subjects: 110
Study 29609566 — intervention group
Group type: EXPERIMENTAL
Intervention: Paracetamol intake
Number of subjects: 110
Study 26105516 — intervention group
Group type: EXPERIMENTAL
Intervention: Amino acid jelly Inner Power(®) (IP) once daily for 21 days
Number of subjects: 59
Study 26105516 — intervention group
Group type: COMPARATOR
Intervention: Regular care
Number of subjects: 59
Study 25532503 — intervention group
Group type: EXPERIMENTAL
Intervention: Lafutidine (20 mg)
Number of subjects: 144
Study 25532503 — intervention group
Group type: COMPARATOR
Intervention: Famotidine (40 mg)
Number of subjects: 144
Study 25532503 — intervention group
Group type: EXPERIMENTAL
Intervention: Omeprazole (20 mg)
Number of subjects: 144